CANNABINOIDI: VANTAGGI E RISCHI PER LA SALUTE

1. 1.Cooper, Z.D. (2016). Cooper, Z.D. (2016). Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Current Psychiatry Reports, 18(5), 52.. Current Psychiatry Reports, 18(5), 52.. 2016
   Articolo scientificoCurrent Psychiatry Reports, 18(5), 52.Leggi il PDF gratuito
2. 2.Devinsky, O., Cross, J.H., Laux, L., Marsh, E., Miller, I., Nabbout, R., ... & Friedman, D. (2017).. Devinsky, O., Cross, J.H., Laux, L., Marsh, E., Miller, I., Nabbout, R., ... & Friedman, D. (2017). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 376(21), 2011–2020.. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome.. 2017
   Articolo scientificoTrial of cannabidiol for drug-resistant seizures in the Dravet syndrome.Leggi il PDF gratuito
3. 3.Hall, W. (2015). Hall, W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction, 110(1), 19–35.. Addiction, 110(1), 19–35.. 2015
   Articolo scientificoAddiction, 110(1), 19–35.Leggi il paperCerca versione gratuita
4. 4.Lu, H.C., & Mackie, K. (2016). Lu, H.C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological Psychiatry, 79(7), 516–525.. Biological Psychiatry, 79(7), 516–525.. 2016
   Articolo scientificoBiological Psychiatry, 79(7), 516–525.Leggi il PDF gratuito
5. 5.NICE (National Institute for Health and Care Excellence) (2019). NICE (National Institute for Health and Care Excellence) (2019). Cannabis-based medicinal products: NICE guideline [NG144]. www.nice.org.uk. Cannabis-based medicinal products: NICE guideline [NG144]. 2019
   NICE (National Institute for Health and Care Excellence) (2019). Cannabis-based medicinal products: NICE guideline [NG144]. www.nice.org.uk
   LibroCerca su Amazon
6. 6.Pacher, P., Bátkai, S., & Kunos, G. (2006). Pacher, P., Bátkai, S., & Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews, 58(3), 389–462.. Pharmacological Reviews, 58(3), 389–462.. 2006
   Articolo scientificoPharmacological Reviews, 58(3), 389–462.Leggi il paperCerca versione gratuita
7. 7.Stout, S.M., & Cimino, N.M. (2014). Stout, S.M., & Cimino, N.M. (2014). Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metabolism Reviews, 46(1), 86–95.. Drug Metabolism Reviews, 46(1), 86–95.. 2014
   Articolo scientificoDrug Metabolism Reviews, 46(1), 86–95.Leggi il paperCerca versione gratuita
8. 8.Turcotte, C., Blanchet, M.R., Laviolette, M., & Flamand, N. (2015).. Turcotte, C., Blanchet, M.R., Laviolette, M., & Flamand, N. (2015). The CB2 receptor and its role as a regulator of inflammation. Cellular and Molecular Life Sciences, 73(23), 4449–4470.. Cellular and Molecular Life Sciences, 73(23), 4449–4470.. 2015
   Articolo scientificoCellular and Molecular Life Sciences, 73(23), 4449–4470.Leggi il PDF gratuito
9. 9.Volkow, N.D., Baler, R.D., Compton, W.M., & Weiss, S.R.B. (2014. Volkow, N.D., Baler, R.D., Compton, W.M., & Weiss, S.R.B. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219–2227.. New England Journal of Medicine, 370(23), 2219–2227.. 2014
   Articolo scientificoNew England Journal of Medicine, 370(23), 2219–2227.Leggi il paperCerca versione gratuita
10. 10.Whiting, P.F., Wolff, R.F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A.V., ... & Kleijnen, J. (2015). Whiting, P.F., Wolff, R.F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A.V., ... & Kleijnen, J. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA, 313(24), 2456–2473.. JAMA, 313(24), 2456–2473.. 2015
    Articolo scientificoJAMA, 313(24), 2456–2473.Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).